Morning Overview on MSN

FDA clears 1st dual-action eye drop to fight age-related vision loss

Age-related near vision loss has long been treated as an inevitable annoyance of getting older, a slow erosion of clarity ...
New Atlas

FDA approves first dual-action eye drop for age-related vision loss

The US Food and Drug Administration has approved a landmark eye drop that uses a combined dose of medication to restore ...
Dealbreaker on MSN

Presbyopia eye drop from startup Tenpoint gets FDA approval, paving way for $235M financing

Tenpoint Therapeutics’ Yuvezzi brings a combination approach to presbyopia compared to single mechanisms of action offered by once-daily eye drops from Orasis Pharmaceuticals, Lenz Therapeutics, and ...

Tenpoint Therapeutics Ltd. Announces FDA Approval of YUVEZZI(TM), the First and Only Combination Eye Drop Approved to Treat Presbyopia

YUVEZZI (TM) (carbachol and brimonidine tartrate ophthalmic solution) 2.75%/0.1% is a dual-agent eye drop approved by the U.S. Food & Drug Administration (FDA) for the treatment of presbyopia, a ...